Giora Hahn, MD in Aspen, CO - Medicare Pain Management

Giora Hahn, MD is a medicare enrolled "Anesthesiology - Pain Medicine" physician in Aspen, Colorado. He went to University Of Missouri, Kansas City, School Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Pain Management. He is a member of the group practice Valley View Hospital Association and his current practice location is 401 Castle Creek Rd, Aspen, Colorado. You can reach out to his office (for appointments etc.) via phone at (970) 544-1146.

Giora Hahn is licensed to practice in Colorado (license number 34791) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1417924838.

Contact Information

	Giora Hahn, MD
	401 Castle Creek Rd, Aspen, CO 81611-1159
	(970) 544-1146
	(970) 544-7687

Physician's Profile

Full Name	Giora Hahn
Gender	Male
Speciality	Pain Management
Experience	33 Years
Location	401 Castle Creek Rd, Aspen, Colorado
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Giora Hahn attended and graduated from University Of Missouri, Kansas City, School Of Medicine in 1991

NPI Data:

NPI Number: 1417924838
Provider Enumeration Date: 03/03/2006
Last Update Date: 05/09/2013

Medicare PECOS Information:

PECOS PAC ID: 3779565643
Enrollment ID: I20041007000405

Medical Identifiers

Medical identifiers for Giora Hahn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417924838	NPI	-	NPPES
P00062257	Other	CO	RR MEDICARE
01347913	Medicaid	CO

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207LP2900X	Anesthesiology - Pain Medicine	34791 (Colorado)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Valley View Hospital Association	Glenwood springs, CO	Hospital
Grand River Hospital District	Rifle, CO	Hospital
Aspen Valley Hospital	Aspen, CO	Hospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Giora Hahn allows following entities to bill medicare on his behalf.

Entity Name	Valley View Hospital Association
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1730897109 PECOS PAC ID: 1850294778 Enrollment ID: O20040129000027

News Archive

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has received its first purchase order for DAVANAT from PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. Pro-Pharmaceuticals has received a purchase order for $200,000 which will be the upfront payment for this first shipment of DAVANAT.

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

Young athletes who do not achieve a 90 percent score on a battery of tests that measure fitness to return to athletic competition, including quadricep strength, are at increased risk for a second knee injury, according to research presented at the Annual Meeting of the American Orthopedic Society of Sports Medicine.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older.

Entity Name	Aspen Pain Practice Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1992772396 PECOS PAC ID: 6709868672 Enrollment ID: O20040603001179

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Entity Name	Grand Mesa Spine And Sport Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1700220993 PECOS PAC ID: 0648408625 Enrollment ID: O20140121001099

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Giora Hahn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Giora Hahn, MD Po Box 1547, Sedalia, MO 65302-1547 Ph: (660) 826-5960	Giora Hahn, MD 401 Castle Creek Rd, Aspen, CO 81611-1159 Ph: (970) 544-1146

News Archive

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Anesthesiology Doctors in Aspen, CO

Dr. Jon Christopher Beck, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 Castle Creek Rd, Aspen, CO 81611 Phone: 970-925-1120 Fax: 970-544-1587
Dr. Eric Willsky, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 401 Castle Creek Rd, Aspen, CO 81611 Phone: 970-925-1120 Fax: 970-544-1587

Giora Hahn, MD - Medicare Pain Management in Aspen, CO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Medicare Reassignments

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Young athletes who fail to score 90% on fitness tests have higher risk of second knee injury

New 'super food' breakthrough in sports nutrition

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

Anesthesiology Doctors in Aspen, CO